Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years - Sánchez-Piedra, Carlos; Sueiro-Delgado, Diana; García-González, Javier; Ros-Vilamajo, Inmaculada; Prior-Español, Agueda; Moreno-Ramos, Manuel José; Garcia-Magallon, Blanca; Calvo-Gutiérrez, Jerusalen; Perez-Vera, Yanira; Martín-Domenech, Raquel; Ruiz-Montesino, Dolores; Vela-Casasempere, Paloma; et al. (Scientific reports, 2021)
Keywords: 692/308; 692/4023; 692/4023/1670; Ankylosing spondylitis; Antirheumatic Agents - therapeutic use; Arthritis; Arthritis, Psoriatic - drug therapy; Arthritis, Psoriatic - epidemiology; Arthritis, Psoriatic - pathology; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - epidemiology; Arthritis, Rheumatoid - pathology; Biosimilar Pharmaceuticals - therapeutic use; Corticoids; Corticosteroids; Disease; Female; Generalized linear models; Humanities and Social Sciences; Humans; Male; Middle Aged; multidisciplinary; Patients; Psoriatic arthritis; Registries; Retention; Rheumatic Diseases - drug therapy; Rheumatic Diseases - epidemiology; Rheumatic Diseases - pathology; Rheumatoid arthritis; Science; Science (multidisciplinary); Spain - epidemiology; Spondylitis, Ankylosing - drug therapy; Spondylitis, Ankylosing - epidemiology; Spondylitis, Ankylosing - pathology; Therapeutic applications; Tumor Necrosis Factor Inhibitors - therapeutic use; Spain